Adaptive Biotechnologies (ADPT) reported 41.87millioninrevenueforthequarterendedMarch2024,representingayear−over−yearincreaseof11.20.33 for the same period compares to -0.40ayearago.Thereportedrevenuerepresentsasurpriseof−0.7842.2 million. With the consensus EPS estimate being -$0.35, the EPS surprise was +5.71%.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectatio ...